Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Rich-Pharm Pharmaceutical is a Chinese pharmaceutical company that specializes in the development and manufacturing of anti-infective medications. As a subsidiary of the publicly traded Hainan Ruize New Building Material Co., Ltd., the company operates extensive GMP-certified production lines for powder injections, small-volume injections, and solid oral dosages. Its core product portfolio focuses on cephalosporin antibiotics and other essential generic drugs aimed at the domestic Chinese healthcare market. The company provides both proprietary products and contract manufacturing services, maintaining a significant presence in the regional pharmaceutical industry of Hainan province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Rich-Pharm Pharmaceutical.